US2019330618A1PendingUtilityA1
Enzymatic encoding methods for efficient synthesis of large libraries
Est. expiryDec 1, 2025(expired)· nominal 20-yr term from priority
Inventors:Thomas FranchMikkel Dybro LundorfSøren Nyboe JakobsenEva Kampmann OlsenAnne Lee AndersenAnette HoltmannAnders Holm HansenAnders Malling SørensenAnne GoldbechDaen De LeonDitte Kievsmose KaldorFrank Abildgaard SløkGitte Nystrup HusemoenJohannes DolbergKim Birkebæk JensenLene Raunkjaer PetersenMads Nørregaard-MadsenMichael Anders GodskesenSanne Schrøder GladSøren NeveThomas ThistedTine Titilola Akinleminu KronborgChristian Klarner SamsJakob FeldingPer-Ola FreskgardAlex Haahr GouliaevHenrik Pedersen
C12N 15/1089C40B 50/04C40B 50/06C40B 40/08C12N 15/1068
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a method for obtaining a bifunctional complex comprising a molecule linked to a single stranded identifier oligonucleotide, wherein a nascent bifunctional complex comprising a chemical reaction site and a priming site for enzymatic addition of a tag is a) reacted at the chemical reaction site with one or more reactants, and b) reacted enzymatically at the priming site with one or more tag(s) identifying the reactant(s).
Claims
exact text as granted — not AI-modified1 - 161 . (canceled)
162 . A split-and-mix method for synthesising a library of different bifunctional complexes comprising a small molecule linked to an identifier oligonucleotide, the method comprising:
i) dividing a plurality of nascent bifunctional complexes comprising a nascent small molecule linked to one or more oligonucleotide tags into multiple fractions; ii) reacting a reactant with said nascent bifunctional molecule; iii) chemically ligating a single stranded oligonucleotide tag identifying said reactant to an oligonucleotide tag of said nascent bifunctional molecule, iv) providing one or more anti-tags capable of hybridizing to one or more chemically ligated oligonucleotide tags; v) hybridizing said one or more anti-tags to said one or more chemically ligated oligonucleotide tags after each synthesis round or after a final round of synthesis; vi) polymerase extending said anti-tags to generate complementary oligonucleotide tags; and vii) enzymatically or chemically ligating said complementary oligonucleotide tags.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.